Get started
Author

Heidi Griesmann

Observed names: Griesmann, H., Griesmann, Heidi, H Griesmann, H. Griesmann
Observed institutions: Philipps University of Marburg, University of Würzburg, Universitätsklinikum Gießen und Marburg, University Hospital Zurich, University Hospital in Halle, Martin Luther University Halle-Wittenberg, University of Tübingen
ORCID: 0000-0003-0701-2947
Observed ORCID: 0000-0003-0701-2947
OpenAlex ID: A5035140761
Pharmacological macrophage inhibition decreases metastasis formation in a genetic model of pancreatic cancer
2016 · Heidi Griesmann, Christof Drexel, et al. · Gut · 130
Genome-wide association study identifies inversion in the CTRB1-CTRB2 locus to modify risk for alcoholic and non-alcoholic chronic pancreatitis
2017 · Jonas Rosendahl, Holger Kirsten, et al. · Gut · 129
PDF
p53 family members in myogenic differentiation and rhabdomyosarcoma development
2006 · Hakan Cam, Heidi Griesmann, et al. · Cancer Cell · 109
PDF
WNT5A-NFAT Signaling Mediates Resistance to Apoptosis in Pancreatic Cancer
2013 · Heidi Griesmann, Stefanie Ripka, et al. · Neoplasia · 82
PDF
Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions
2012 · Albrecht Neesse, Anke Hahnenkamp, et al. · Gut · 77
Context-Dependent Epigenetic Regulation of Nuclear Factor of Activated T Cells 1 in Pancreatic Plasticity
2017 · Nai-Ming Chen, Albrecht Neesse, et al. · Gastroenterology · 53
Claudin-4 as therapeutic target in cancer
2012 · A. Neesse, H. Griesmann, et al. · Archives of Biochemistry and Biophysics · 51
p73 poses a barrier to malignant transformation by limiting anchorage‐independent growth
2008 · Michaela Beitzinger, Lars Hofmann, et al. · The EMBO Journal · 51
PDF
Therapeutic targeting of tumor‐associated macrophages in pancreatic neuroendocrine tumors
2018 · Sebastian Krug, Rami Abbassi, et al. · International Journal of Cancer · 49
PDF
Glutamate Receptor GRIA3—Target of CUX1 and Mediator of Tumor Progression in Pancreatic Cancer
2010 · Stefanie Ripka, Jan Riedel, et al. · Neoplasia · 49
PDF
CUX1 modulates polarization of tumor-associated macrophages by antagonizing NF-κB signaling
2013 · B Kühnemuth, L Mühlberg, et al. · Oncogene · 39
Synthetic Lethality Screen Identifies RPS6KA2 as Modifier of Epidermal Growth Factor Receptor Activity in Pancreatic Cancer
2013 · Nada Milosevic, Benjamin Kühnemuth, et al. · Neoplasia · 38
PDF
Common variants in the CLDN2-MORC4 and PRSS1-PRSS2 loci confer susceptibility to acute pancreatitis
2018 · Frank Ulrich Weiss, Nico Hesselbarth, et al. · Pancreatology · 26
PDF
The p53 family inhibitor ΔNp73 interferes with multiple developmental programs
2005 · N Hüttinger-Kirchhof, H Cam, et al. · Cell Death and Differentiation · 25
miRNA dynamics in tumor-infiltrating myeloid cells modulating tumor progression in pancreatic cancer
2016 · Leonie Mühlberg, Benjamin Kühnemuth, et al. · OncoImmunology · 22
PDF
Common variants in glyoxalase I do not increase chronic pancreatitis risk
2019 · Tom Kaune, Marcus Hollenbach, et al. · PLoS ONE · 20
PDF
Modulation of Pancreatic Neuroendocrine Neoplastic Cell Fate by Autophagy-Mediated Death
2020 · Sami Matrood, Nicola de Prisco, et al. · Neuroendocrinology · 16
CUX1: a modulator of tumour aggressiveness in pancreatic neuroendocrine neoplasms
2014 · Sebastian Krug, Benjamin Kühnemuth, et al. · Endocrine Related Cancer · 15
PDF
CUX1 Enhances Pancreatic Cancer Formation by Synergizing with KRAS and Inducing MEK/ERK-Dependent Proliferation
2021 · Heidi Griesmann, Sebastian Mühl, et al. · Cancers · 14
PDF
IGF2BP1 Promotes Proliferation of Neuroendocrine Neoplasms by Post-Transcriptional Enhancement of EZH2
2022 · Florian Sperling, Danny Misiak, et al. · Cancers · 13
PDF
Gender-Specific Changes of the Gut Microbiome Correlate with Tumor Development in Murine Models of Pancreatic Cancer
2022 · Tom Kaune, Heidi Griesmann, et al. · iScience · 12
PDF
Anti-angiogenic therapy using the multi-tyrosine kinase inhibitor Regorafenib enhances tumor progression in a transgenic mouse model of ß-cell carcinogenesis
2023 · Maren Juliane Egidi, Sebastian Krug, et al. · British Journal of Cancer · 10
PDF
p53 and p73 in suppression of Myc‐driven lymphomagenesis
2008 · Heidi Griesmann, Katharina Schlereth, et al. · International Journal of Cancer · 9
PDF
Serum levels of advanced glycation end products and their receptors sRAGE and Galectin-3 in chronic pancreatitis
2019 · Richard Böhme, Carla Becker, et al. · Pancreatology · 7
Hereditary chronic pancreatitis induced plasticity cooperates with mutant Kras in early pancreatic carcinogenesis
2025 · Tanvi Vikrant Inamdar, Ferdinand Krannich, et al. · Gut · 5
PDF
Works count: 72
Citation count: 1,056
H-index: 16
I10-index: 22
Year
Topic
Type